WallStSmart
PLX

Protalix Biotherapeutics Inc

NYSE MKT: PLX · HEALTHCARE · BIOTECHNOLOGY

$2.02
+3.06% today

Updated 2026-05-06

Market cap
$170.81M
P/E ratio
P/S ratio
3.24x
EPS (TTM)
$-0.08
Dividend yield
52W range
$1 – $3
Volume
0.9M

Protalix Biotherapeutics Inc (PLX) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-5.09M$-10.45M$-16.02M$44.45M$-38.46M$-23.57M$635000.00$-30.65M$-29.28M$-24.28M$-32.10M$-9.99M$-7.74M$-19.36M$-26.11M$-10.29M$-25.00M$-1.32M$8.67M$-11.99M
Capital expenditures$842000.00$2.33M$3.37M$6.20M$7.86M$5.71M$2.07M$1.89M$785000.00$464000.00$849000.00$971000.00$686000.00$627000.00$655000.00$1.46M$628000.00$1.15M$1.28M$1.64M
Depreciation
Stock-based comp$3.42M$10.85M$3.07M$2.68M$1.28M$886000.00$7.75M$4.09M$1.24M$1.80M$988000.00$337000.00$514000.00$835000.00$3.13M$2.38M$2.08M$3.45M$3.25M$2.30M
Free cash flow$-5.93M$-12.78M$-19.39M$38.26M$-46.32M$-29.27M$-1.43M$-32.54M$-30.07M$-24.75M$-32.95M$-10.96M$-8.43M$-19.98M$-26.76M$-11.74M$-25.63M$-2.47M$7.39M$-13.63M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-15.05M$18.38M$-26.66M$-29.43M$21.61M$-13.09M$-12.12M$498000.00$835000.00